Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo

• Egile Nagusiak: Jean-Claude Makenga Bof (Egilea), Daniel Muteba (Egilea), Paul Mansiangi (Egilea), Félicien Ilunga-Ilunga (Egilea), Yves Coppieters (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The progress of mass, community-directed, treatment with ivermectin (CDTI) for onchocerciasis control was disrupted by severe adverse effects (SAE) in the Democratic Republic of Congo (DRC). The study aimed at determining the frequency of post-CDTI SAE as well as factors associat...